American Computer Innovators, Inc. v. Electronic Data Systems Corp.

74 F. Supp. 2d 64, 53 Fed. R. Serv. 107, 1999 U.S. Dist. LEXIS 17484, 1999 WL 1021049
CourtDistrict Court, D. Massachusetts
DecidedNovember 8, 1999
DocketCiv.A. 95-30202-MAP
StatusPublished
Cited by1 cases

This text of 74 F. Supp. 2d 64 (American Computer Innovators, Inc. v. Electronic Data Systems Corp.) is published on Counsel Stack Legal Research, covering District Court, D. Massachusetts primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
American Computer Innovators, Inc. v. Electronic Data Systems Corp., 74 F. Supp. 2d 64, 53 Fed. R. Serv. 107, 1999 U.S. Dist. LEXIS 17484, 1999 WL 1021049 (D. Mass. 1999).

Opinion

MEMORANDUM REGARDING EXPERT TESTIMONY

PONSOR, District Judge.

American Computer Innovators, Inc. (“ACI”) has sued Electronic Data Systems Corporation (“EDS”), charging EDS with breach of contract, misappropriation of certain confidential information and fraudulent inducement. This memorandum will address the limited issue of whether plaintiff will be permitted to offer certain expert testimony at trial. A brief summary of the underlying facts will suffice to focus the discussion.

According to plaintiff, prior to August 1994, defendant EDS had contracted with a third party, Dow Jones; to replace its “copy-flow” system. This planned data processing system, designated by Dow Jones as its Global News Management System (“GNMS”), would track and control editorial copy from the reporter’s notes to the eventual news story as it would appear in the Wall Street Journal. One of the products being considered for use in the GNMS was “DewarView,” a preexisting software system that EDS hoped to modify for Dow Jones.

By August 1994 EDS was encountering serious problems in developing a system that met the Dow Jones’ specifications. According to plaintiff, EDS then entered into discussions with ACI to obtain ACI’s assistance in evaluating and revising the DewarView product. Within a few weeks ACI advised EDS that DewarView would not suit its needs, but that ACI could identify another product, or group of products, that would allow EDS to develop the GNMS.

On October 6, 1994, ACI and EDS signed a Letter of Agreement with the understanding, according to plaintiff, that the parties would enter into a formal contract thereafter. The letter stated that, with certain limitations, any disclosures made by ACI constituted ACI’s intellectual property, that ACI would be paid at a rate to be negotiated if Dow Jones used its copy flow solution, and that ACI and EDS would share in the discoveries made during the implementation process. In addition, EDS agreed to keep the ACI solutions confidential, and to allow ACI to publish press releases and make other public statements regarding the importance of ACI’s contribution to the GNMS *66 project “subject to approval by Dow Jones.” See, Ex. A to Defendant’s Memorandum in Support of Reconsideration, Dkt. No. 110.

In the following weeks ACI says it disclosed certain confidential information to EDS that provided a solution to the difficulties EDS had been encountering in developing the GNMS for Dow Jones. Plaintiff claims that EDS, having obtained the information it wanted, began stalling and, in the end, refused to enter into a formal contract with ACI on the terms contemplated by the parties’ original discussions and the letter of intent. For its part, EDS contends that Dow Jones simply lost confidence in the kind of products ACI was proposing for the GNMS — its “solution” solved nothing — -with the result that there was no point in continuing down the path ACI had marked out. Whatever the reason, on January 12, 1995, a little over three months after the letter of agreement was signed, EDS terminated its working relationship with ACI. It is apparently undisputed that in the years since ACI initiated this lawsuit, EDS has, in fact, never been able to develop a copy-flow system satisfactory to Dow Jones; recently Dow Jones has scrapped the entire GNMS project with a loss of several million dollars.

EDS contends that none of the disclosures made by ACI constituted or contained anything that might be considered legally protected confidential information. Moreover, EDS vigorously denies breaching any contract with ACI, misappropriating any confidential information or fraudulently inducing ACI into making any disclosures. Finally, and most significantly for purposes of this memorandum, EDS contends that ACI suffered no significant damages, because any obligation to license ACI’s proposed solution, or make any payments to ACI, was conditioned upon the use of ACI’s solution by EDS’s customer, Dow Jones — a use which has never occurred and, it now appears, will never occur.

During the latter stages of discovery, plaintiff identified several technical and damage experts, proposing to offer them to show that EDS did misappropriate its intellectual property and that ACI suffered damages as a result. Defendant moved in limine to exclude all their testimony, and the court denied these motions without prejudice. Defendant thereafter sought a pretrial hearing regarding the admissibility of the experts’ testimony, on the authority of Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 (1993). In order to understand this court’s approach to the expert issue, it is necessary to look in some detail at Daubert and its progeny.

Jason Daubert was a minor child born with serious birth defects, allegedly caused by his mother’s ingestion of Bendectin, a prescription antinausea drug marketed by the defendant. The district court granted Dow’s Motion for Summary Judgment, holding that the scientific evidence suggesting that Bendectin could cause birth defects lacked sufficient general acceptance in the scientific field. The Court of Appeals for the Ninth Circuit affirmed the grant of summary judgment, citing the rule of “general acceptance” first set forth in Frye v. United States, 54 App.D.C. 46, 47, 293 F. 1013, 1014 (1923), which then governed the evaluation of the admissibility of expert testimony.

The Supreme Court’s Daubert decision jettisoned the Frye test, holding that it was displaced by the adoption of the Federal Rules of Evidence. Under Fed. R.Evid. 702, the central question is whether the expert’s testimony will “assist the trier of fact to understand the evidence or to determine a fact in issue.” Fed.R.Evid. 702. To evaluate whether an expert’s testimony will assist the jury, the trial judge must, first, confirm that the testimony is relevant and, second, make a “preliminary assessment of whether the reasoning or methodology underlying the testimony is scientifically valid and ... whether that reasoning or methodology properly can be *67 applied to the facts in issue.” Daubert, at 592-93, 113 S.Ct. 2786. Daubert suggests that key questions in making this assessment might include: whether the theory or technique can be tested, whether it has been subjected to peer review and publication, whether the theory or technique exhibits a known or potential rate of error, and whether it is in fact generally accepted. See Id., at 593-94, 113 S.Ct. 2786.

In weighing the admissibility of the proposed expert testimony, the court must keep in mind as well that the inquiry under Rule 702 is flexible. The points of inquiry proposed by Justice Blackmun in Daubert are examples only and not intended to limit the tools that might be used by a judge to test the reliability of the proposed testimony.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

CHAPMAN EX REL. EST. OF CHAPMAN v. Bernard's Inc.
167 F. Supp. 2d 406 (D. Massachusetts, 2001)

Cite This Page — Counsel Stack

Bluebook (online)
74 F. Supp. 2d 64, 53 Fed. R. Serv. 107, 1999 U.S. Dist. LEXIS 17484, 1999 WL 1021049, Counsel Stack Legal Research, https://law.counselstack.com/opinion/american-computer-innovators-inc-v-electronic-data-systems-corp-mad-1999.